Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound

NEUROPHARMACOLOGY

卷:120

Review

Poon, Charissa^1,3  McMahon, Dallan^2,3  Hynynen, Kullervo^1,2,3 

[1] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada

[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada

[3] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada

关键词: Blood-brain barrier;    Focused ultrasound;    Microbubbles;    Noninvasive surgery;    Drug delivery;    MRI;   

DOI  :  10.1016/j.neuropharm.2016.02.014

来源: Elsevier

【 摘 要 】

The range of therapeutic treatment options for central nervous system (CNS) diseases is greatly limited by the blood-brain barrier (BBB). While a variety of strategies to circumvent the blood-brain barrier for drug delivery have been investigated, little clinical success has been achieved. Focused ultrasound (FUS) is a unique approach whereby the transcranial application of acoustic energy to targeted brain areas causes a noninvasive, safe, transient, and targeted opening of the BBB, providing an avenue for the delivery of therapeutic agents from the systemic circulation into the brain. There is a great need for viable treatment strategies for CNS diseases, and we believe that the preclinical success of this technique should encourage a rapid movement towards clinical testing. In this review, we address the versatile applications of FUS-mediated BBB opening, the safety profile of the technique, and the physical and biological mechanisms that drive this process. This article is part of the Special Issue entitled Beyond small molecules for neurological disorders. (C) 2016 Elsevier Ltd. All rights reserved.

【 授权许可】

Free